ݺߣ

ݺߣShare a Scribd company logo
VBMS 7180 Receptorology
Presented by: Chris Ramhold Ph.D. Student
16-March-15
TYROSINE SULFATION OF THE AMINO TERMINUS
OF CCR5 FACILITATES HIV-1 ENTRY
? Setting the stage
? Post-translational modification
C Tyrosine Sulfation
? Chemokine receptors
C What are chemokine receptors?
? Characteristics and families
C How do chemokine receptors work?
C CCR5
? HIV
C Classification
? Primary research article
OVERVIEW
? Previously studied N-
terminus region of
CCR5
? Site directed
mutagenesis
PRIOR RESEARCH
Farzan, Michael, et al. "A tyrosine-rich region in the N terminus of CCR5 is important for human immunodeficiency virus type 1 entry and mediates an association between gp120 and CCR5." Journal of virology 72.2
(1998): 1160-1164.
? N-terminus important
for internalization
? Found something
interesting
? Half of the mutants
were originally
tyrosine
PRIOR RESEARCH
Farzan, Michael, et al. "A tyrosine-rich region in the N terminus of CCR5 is important for human immunodeficiency virus type 1 entry and mediates an association between gp120 and CCR5." Journal of virology 72.2
(1998): 1160-1164.
? Aromatic- Benzene
? Reactive hydroxyl group
? Can be phosphorylated or
sulfated
QUICK REVIEW- TYROSINE
? Modifications
occurring after
translation
? Responsible for
proteome diversity
? Most often includes
covalent
attachment of
functional groups
POSTTRANSLATIONAL MODIFICATION
http://asfaculty.syr.edu/pages/chem/_images/hougland_fig1.jpg
? The transfer of a sulfate to
the hydroxyl group of the
tyrosine residue
? Enzymatic assistance by
tyrosylprotein
sulfotransferase (TPST)
? Occurs in the golgi
? Donor molecule 3-
phosphoadenosine-
5phosphosulfate (PAPS)
TYROSINE SULFATION
Kanan, Yogita, and Muayyad R. Al-Ubaidi. "Tyrosine OSulfation: An Overview." JSM 1.1 (2013): 1003.
? Receptors for cytokines
that induce chemotaxis
? 7TM structure
C Member of GPCR
? Four classes
C C, CC, CXC, and CX3C
CHEMOKINE RECEPTORS
http://www.biolegend.com/media_assets/chemokine_receptors/CK_structure.jpg
? Chemokine binds N-terminus of receptor
C Binding enhanced by tyrosine sulfation
? Complex interacts with cytoplasmic face of receptor to
activate signaling
CHEMOKINE RECEPTOR BINDING MODEL
Ludeman, Justin P., and Martin J. Stone. "The structural role of receptor tyrosine sulfation in chemokine recognition." British journal of pharmacology 171.5 (2014): 1167-1179.
? Expressed on T-cells,
macrophages, dendritic
cells, eosinophils and
microglia
? Most common receptor for
HIV-1 internalization
? Most common target of HIV
drugs
C CCR5 receptor antagonists
C Maraviroc (Pfizer)
C Block CCR5 binding site
CHEMOKINE RECEPTOR TYPE 5
http://idshowcase.lshtm.ac.uk/id501/ID501/S1S4/ID501_S1S4_030_010.html
? Human immunodeficiency virus
(HIV)
C Lentivirus, group of retroviruses
? Cause of AIDS (acquired
immunodeficiency syndrome)
? Viral RNA is reverse transcribed
and integrated into host DNA
? Infects immune cells
C CD4+ T cells
C Macrophages
C Dendritic cells
HIV
http://s.hswstatic.com/gif/aids-hiv-anatomy.gif
? HIV-1
C High virulence
C High infectivity
C Global
? HIV-2
C Moderate virulence
C Low infectivity
C Localized to West
Africa
HIV CLASSIFICATIONS
http://treasuresoftheinternet.org/health/aids/us_census/aids_maps/Map3c.gif
? Research group
published paper
regarding N-terminus
of CCR5 receptor
? Gradual increase in
focus
? Need to identify
targets for HIV therapy
THE PAPER
? N-terminal CCR5 residues
important
? Tyrosines specifically
? Sulfate plays several roles in
HIV-1 internalization
C Virus-cell interactions
C Inhibit internalization by
binding gp120*
C Inhibit viral replication
TYROSINE SULFATION OF THE AMINO TERMINUS OF
CCR5 FACILITATES HIV-1 ENTRY
Baleux, Fran?oise, et al. "A synthetic CD4Cheparan sulfate glycoconjugate inhibits CCR5 and CXCR4 HIV-1 attachment and entry." Nature chemical biology 5.10 (2009): 743-748.
? Sulfation common in
chemokines and HIV-1 env
glycoproteins
? Is CCR5 sulfated?
? Red- Negative controls
? Blue- Stably transfected
CD4/CCR5
? Sulfate is specifically
incorporated in CCR5
POSTTRANSLATIONAL MODIFICATION BY SULFATE
[35S] C [35S] M [35S] Sulfate
CCR5 CCR5CD4 CD4
Label
IP
? Sulfation occurs at either O-, N-linked glycosylation sites,
or on tyrosines
? Endoglycosidase F (endo F) & Tunicamycin treatment
ineffective against CCR5
C Cleavage and blockage of N-linked glycosylation
C Not N-linked glycosylation
CCR5 SITE OF SULFATION (N-LINKED GLYCOSYLATION)
? Red- Negative controls
C No expression of CD4 or CCR5
? IP with CCR5 antibody
? 1, 4, 5, & 8- Enzyme buffer
? 2 & 6 - Neuraminidase (green)
? 3 & 7 C Four O-glycosidases
(yellow)
? [35S] Sulfate still present after
treatments
C Sulfation must occur on tyrosines
CCR5 SITE OF SULFATION (O-LINKED GLYCOSYLATION)
[35S] Sulfate [35S] C & M
? Thin layer chromatography
? Labeled CCR5 from previous
experiment removed from gel
? Digested, pH neutralized, and
run next to unlabeled tyrosine
and serine sulfates (1 & 3)
? 2 & 4 show presence of
labeled Tyrosine sulfate
? Presence of 35S due to Tyrosine
sulfation
CCR5 MODIFICATIONS (TYROSINE SULFATION)
Ninhydrin X-ray film
? Negative control cells treated with
sulfate (white)
? Treatment with chlorate- inhibit
sulfation (gray)
? Treatment with sulfate- allow
sulfation (thick line)
? 2D7- Antibody specific to 2nd
extracellular loop
? No difference between treatments
? Sulfation does not interfere with
binding- no alteration in 2nd
extracellular loop
ROLE OF TYROSINE SULFATION
FACS- Fluorescence Activated
Cell Sorting
? Negative control cells treated with
sulfate (white)
? Treatment with chlorate- inhibit
sulfation (gray)
? Treatment with sulfate- allow sulfation
(thick line)
? 5C7- Antibody specific to N terminus
? Decreased binding of 5C7 when
sulfation is inhibited
? N-terminus recognition altered
? No effect on CCR5 expression levels
(AUC)
ROLE OF TYROSINE SULFATION
FACS- Fluorescence Activated
Cell Sorting
? Confirmation of results
C Mutated tyrosine to phenylalanine
C Similar results (data not shown)
C Decreased recognition specific to loss of sulfate
ROLE OF TYROSINE SULFATION
? Chlorate treatment (circles/red)
? Sulfate treatment (squares/blue)
? 125I-labeled MIP-1a incubated
with CCR5 transfected cells
? Increasing amounts of MIP-1a
competitor added
? Loss of sulfate leads to
decreased binding of native
ligand MIP-1a
? Sulfate-treated cells with 2D7
antibody (diamond)
? Negative control cells (triangle)
ROLE OF TYROSINE SULFATION (CCR5 LIGANDS)
MIP= Macrophage inflammatory
protein-1a a.k.a. CCL3
? Chlorate treatment (circles/red)
? Sulfate treatment (squares/blue)
? 125I-labeled MIP-1 incubated
with CCR5 transfected cells
? Increasing amounts of MIP-1
competitor added
? Loss of sulfate leads to
decreased binding of native
ligand MIP-1
? Sulfate-treated cells with 2D7
antibody (diamond)
? Negative control cells (triangle)
ROLE OF TYROSINE SULFATION (CCR5 LIGANDS)
MIP= Macrophage inflammatory
protein-1 a.k.a. CCL4
? Chlorate treatment (circles/red)
? Sulfate treatment (squares/blue)
? 125I-labeled gp120 complexed
with soluble CD4 incubated with
CCR5 transfected cells
? Typically binds with high affinity
? Loss of sulfate leads to decreased
binding efficiency
? Sulfate-treated cells with 2D7
antibody (diamond)
? Negative control cells (triangle)
ROLE OF TYROSINE SULFATION (CCR5 LIGANDS)
sYU2- HIV-1 env gp120, strain YU2
? Which of the four tyrosines are sulfated?
? CCR5 construct used
? Nine amino acid tag
C Motif from rhodopsin
C Identified with anti-rhodopsin antibody 1D4
? New cell line used
C HeLa cells
C Six transfection lines created
? Mock transfection- Empty vector
? All four tyrosines replaced with phenylalaline
? Four constructs where three of four tyrosines are replaced with
phenylalaline
? Assay for sulfation
IDENTIFICATION OF SULFATED TYROSINES
? HeLa transfected cell lysates
? IP with 1D4 antibody
? WT does incorporate sulfate
? FFFF construct fails to
incorporate sulfate
? Only YFFF could incorporate
sulfate
C Faint bands on other 3 constructs
after extended exposure (not
shown)
C FYYY (next 2 slides) showed sulfation
greater than 3 constructs previously
mentioned
IDENTIFICATION OF SULFATED TYROSINES
? HeLa transfected cell lysates
? IP with 1D4 antibody
? WT does incorporate sulfate
? Sulfation greater in three adjacent
tyrosine construct
? Due to the absence of phenylalanine?
? Due to the presence of neighboring
tyrosines?
? Replace phenylalaline with AA that
mimics a sulfated tyrosine
SULFATION DEPENDENT ON NEIGHBORING RESIDUES
? HeLa transfected cell lysates
? IP with 1D4 antibody
? WT does incorporate sulfate
? FFFF construct fails to
incorporate sulfate
? New panel of mutants using
aspartic acid vs phenylalanine
? Sulfation of single tyrosines
? Negative charge may assist in
sulfation of neighboring tyrosines
SULFATION OF CCR5 TYROSINES DEPENDENT ON N-
TERMINAL RESIDUES
? Do sulfotyrosines in CCR5 play
a role in HIV-1 internalization?
? Generate pseudotype viruses
C Virus containing CAT reporter
gene
C Lacking env gene
? Host cell expresses env gene
(pseudotyped gene)
? Generate PV, capable of only
one round of infection
? Use envelope glycoproteins
ADA, YU2, and 89.6 ( from
strains that use CCR5 for entry)
SULFATION OF CCR5 TYROSINES DEPENDENT ON N-
TERMINAL RESIDUES
Tani, Hideki, Shigeru Morikawa, and Yoshiharu Matsuura. "Development and applications of VSV vectors based on cell tropism." Frontiers in microbiology 2 (2011).
? YU2 pseudotyped HIV-1
? WT CCR5 (black squares/
blue)
? FFFF CCR5 construct
(circles/ red)
? Negative control (triangle)
? Lack of tyrosine residues
resulted in decrease of
viral entry
HIV-1 ENTRY EFFICIENCY MODULATED BY SULFATED
TYROSINES
? % entry relative to wild type CCR5
? ADA pseudotyped HIV-1
? WT CCR5 (black squares/
blue)
? FFFF CCR5 construct
(circles/ red)
? Negative control (triangle)
? Lack of tyrosine residues
resulted in greater
decrease of viral entry
relative to YU2
pseudotyped HIV-1
HIV-1 ENTRY EFFICIENCY MODULATED BY SULFATED
TYROSINES
? % entry relative to wild type CCR5
? 89.6 pseudotyped HIV-1
? WT CCR5 (black squares/
blue)
? FFFF CCR5 construct
(circles/ red)
? Negative control (triangle)
? Lack of tyrosine residues
resulted in greatest
decrease of viral entry
relative to all tested
pseudotypes of HIV-1
HIV-1 ENTRY EFFICIENCY MODULATED BY SULFATED
TYROSINES
? % entry relative to wild type CCR5
? YU2 pseudotyped HIV-1
? WT CCR5 (YYYY)
standard
? Test entry mediated by
sulfate group vs phenyl
ring
? Presence of sulfated
tyrosine leads to
significant viral entry
HIV-1 YU2 ENTRY ENHANCED BY SULFATION OF N-
TERMINAL TYROSINE RESIDUES
? ADA pseudotyped HIV-1
? WT CCR5 (YYYY)
standard
? Test entry mediated by
sulfate group vs phenyl
ring
? Presence of sulfated
tyrosine leads to
significant viral entry
HIV-1 ADA ENTRY ENHANCED BY SULFATION OF N-
TERMINAL TYROSINE RESIDUES
? AA sequences of N-
termini of related
receptors
? All but two are known
HIV-1/SIV coreceptors*
? Tyrosines and adjacent
AAs are bolded
DO THESE FINDINGS TRANSLATE TO OTHER RELATED
RECEPTORS?
Receptors incorporating [35S] sulfate
? CXCR4 tested in human embryonic kidney
cells expressing SV40 large T antigen (HEK
293T)
? CXCR4 contained c-terminal tag
recognized by Ab 1D4
? Receptor labeled with [35S] sulfate
? Band indicates presence of [35S] sulfate in
CXCR4 expressing cells
DO THESE FINDINGS TRANSLATE TO OTHER RELATED
RECEPTORS?
? Confirmed CCR5 is sulfated
? Site of sulfation on tyrosines
C Confirmed tyrosine sulfation
? Tyrosine sulfation occurs on N-terminus
C Affects binding but not receptor expression
C Blockage of sulfation leads to decreased binding ability of native ligands
? Tyrosine sulfation enhanced by negative charge of proximal AAs
? Sulfated tyrosines are important in HIV-1 entry
? Sulfation may play a role in other coreceptors and the
internalization of HIV-1
TYROSINE SULFATION OF THE AMINO TERMINUS
OF CCR5 FACILITATES HIV-1 ENTRY
? Baleux, Fran?oise, et al. "A synthetic CD4Cheparan sulfate glycoconjugate inhibits CCR5
and CXCR4 HIV-1 attachment and entry." Nature chemical biology 5.10 (2009): 743-748.
? Farzan, Michael, et al. "A tyrosine-rich region in the N terminus of CCR5 is important for
human immunodeficiency virus type 1 entry and mediates an association between
gp120 and CCR5." Journal of virology 72.2 (1998): 1160-1164.
? Farzan, Michael, et al. "Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1
entry." Cell 96.5 (1999): 667-676.
? Kanan, Yogita, and Muayyad R. Al-Ubaidi. "Tyrosine OSulfation: An Overview." JSM 1.1
(2013): 1003.
? Tani, Hideki, Shigeru Morikawa, and Yoshiharu Matsuura. "Development and
applications of VSV vectors based on cell tropism." Frontiers in microbiology 2 (2011).
? http://asfaculty.syr.edu/pages/chem/_images/hougland_fig1.jpg
? http://www.biolegend.com/media_assets/chemokine_receptors/CK_structure.jpg
? http://s.hswstatic.com/gif/aids-hiv-anatomy.gif
? http://treasuresoftheinternet.org/health/aids/us_census/aids_maps/Map3c.gif
? http://idshowcase.lshtm.ac.uk/id501/ID501/S1S4/ID501_S1S4_030_010.html
REFERENCES

More Related Content

What's hot (9)

Glyco special hart
Glyco special hartGlyco special hart
Glyco special hart
RANGAMANI muralidharan
?
nihms557954
nihms557954nihms557954
nihms557954
Steven Bao
?
T Cells Aggravate Intestinal Inflammation and Fibrosis
T Cells Aggravate Intestinal Inflammation and FibrosisT Cells Aggravate Intestinal Inflammation and Fibrosis
T Cells Aggravate Intestinal Inflammation and Fibrosis
Eric Ma
?
Hla typi ng pg seminar final 0604
Hla typi ng pg seminar final 0604Hla typi ng pg seminar final 0604
Hla typi ng pg seminar final 0604
deepak deshkar
?
October 09 talk
October 09 talkOctober 09 talk
October 09 talk
Sky Lar
?
Lab Meeting 2nd Semester- Investigating genes involved in root growth respons...
Lab Meeting 2nd Semester- Investigating genes involved in root growth respons...Lab Meeting 2nd Semester- Investigating genes involved in root growth respons...
Lab Meeting 2nd Semester- Investigating genes involved in root growth respons...
Megan Stefkovich
?
REU Final PowerPoint
REU Final PowerPointREU Final PowerPoint
REU Final PowerPoint
Alyssa Castle
?
Curriculum Vitae.
Curriculum Vitae.Curriculum Vitae.
Curriculum Vitae.
Dr. DEVANAND KUMAR
?
project- Liron Schwartz
project- Liron Schwartzproject- Liron Schwartz
project- Liron Schwartz
Liron Schwartz
?
T Cells Aggravate Intestinal Inflammation and Fibrosis
T Cells Aggravate Intestinal Inflammation and FibrosisT Cells Aggravate Intestinal Inflammation and Fibrosis
T Cells Aggravate Intestinal Inflammation and Fibrosis
Eric Ma
?
Hla typi ng pg seminar final 0604
Hla typi ng pg seminar final 0604Hla typi ng pg seminar final 0604
Hla typi ng pg seminar final 0604
deepak deshkar
?
October 09 talk
October 09 talkOctober 09 talk
October 09 talk
Sky Lar
?
Lab Meeting 2nd Semester- Investigating genes involved in root growth respons...
Lab Meeting 2nd Semester- Investigating genes involved in root growth respons...Lab Meeting 2nd Semester- Investigating genes involved in root growth respons...
Lab Meeting 2nd Semester- Investigating genes involved in root growth respons...
Megan Stefkovich
?

Viewers also liked (20)

Michigan.com Capabilities
Michigan.com CapabilitiesMichigan.com Capabilities
Michigan.com Capabilities
Nick Oliver
?
Pat Milliken Ford
Pat Milliken FordPat Milliken Ford
Pat Milliken Ford
Nick Oliver
?
10507072 ؔ 104öYo=m
10507072 ؔ 104öYo=m10507072 ؔ 104öYo=m
10507072 ؔ 104öYo=m
releaseey
?
IAQF report_Cornell Team
IAQF report_Cornell TeamIAQF report_Cornell Team
IAQF report_Cornell Team
Jin Li
?
Datasheet Fluke 572-2. Hubungi PT. Siwali Swantika 021-45850618
Datasheet Fluke 572-2. Hubungi PT. Siwali Swantika 021-45850618Datasheet Fluke 572-2. Hubungi PT. Siwali Swantika 021-45850618
Datasheet Fluke 572-2. Hubungi PT. Siwali Swantika 021-45850618
PT. Siwali Swantika
?
International trade unions like ITUC need to be less combative, maybe most ar...
International trade unions like ITUC need to be less combative, maybe most ar...International trade unions like ITUC need to be less combative, maybe most ar...
International trade unions like ITUC need to be less combative, maybe most ar...
Eric Gyllenhaal
?
gebiedsdossier Heelsumse Beek en Wolfhezer Beek
gebiedsdossier Heelsumse Beek en Wolfhezer Beekgebiedsdossier Heelsumse Beek en Wolfhezer Beek
gebiedsdossier Heelsumse Beek en Wolfhezer Beek
Marieke Brouwer-te Molder
?
Osa history
Osa historyOsa history
Osa history
kiran4kumar
?
Grand Traverse Resort deck
Grand Traverse Resort deckGrand Traverse Resort deck
Grand Traverse Resort deck
Nick Oliver
?
Ժ l(ýw溆)
Ժ l(ýw溆)Ժ l(ýw溆)
Ժ l(ýw溆)
releaseey
?
VISHAL AGGARWAL Update
VISHAL AGGARWAL UpdateVISHAL AGGARWAL Update
VISHAL AGGARWAL Update
Vishal Aggarwal
?
Cmsd percuma updated
Cmsd percuma updatedCmsd percuma updated
Cmsd percuma updated
iiza hass
?
HR Tech Advisor #SHRM15 Videos
HR Tech Advisor #SHRM15 Videos HR Tech Advisor #SHRM15 Videos
HR Tech Advisor #SHRM15 Videos
HR Tech Advisor
?
HR Tech Advisor Blog Posts
HR Tech Advisor Blog PostsHR Tech Advisor Blog Posts
HR Tech Advisor Blog Posts
HR Tech Advisor
?
CRISIS MIGRATION: A NEW ROLE TRADE UNION?
CRISIS MIGRATION: A NEW ROLE TRADE UNION? CRISIS MIGRATION: A NEW ROLE TRADE UNION?
CRISIS MIGRATION: A NEW ROLE TRADE UNION?
Eric Gyllenhaal
?
Datasheet Fluke 8508A. Hubungi PT. Siwali Swantika 021-45850618
Datasheet Fluke 8508A. Hubungi PT. Siwali Swantika 021-45850618Datasheet Fluke 8508A. Hubungi PT. Siwali Swantika 021-45850618
Datasheet Fluke 8508A. Hubungi PT. Siwali Swantika 021-45850618
PT. Siwali Swantika
?
Rich ITUC Needs To Do More For Unskilled Laborers, Reports ANI. Report of Sh...
Rich ITUC Needs To Do More For Unskilled Laborers, Reports ANI. Report of Sh...Rich ITUC Needs To Do More For Unskilled Laborers, Reports ANI. Report of Sh...
Rich ITUC Needs To Do More For Unskilled Laborers, Reports ANI. Report of Sh...
Eric Gyllenhaal
?
Michigan.com Capabilities
Michigan.com CapabilitiesMichigan.com Capabilities
Michigan.com Capabilities
Nick Oliver
?
10507072 ؔ 104öYo=m
10507072 ؔ 104öYo=m10507072 ؔ 104öYo=m
10507072 ؔ 104öYo=m
releaseey
?
IAQF report_Cornell Team
IAQF report_Cornell TeamIAQF report_Cornell Team
IAQF report_Cornell Team
Jin Li
?
Datasheet Fluke 572-2. Hubungi PT. Siwali Swantika 021-45850618
Datasheet Fluke 572-2. Hubungi PT. Siwali Swantika 021-45850618Datasheet Fluke 572-2. Hubungi PT. Siwali Swantika 021-45850618
Datasheet Fluke 572-2. Hubungi PT. Siwali Swantika 021-45850618
PT. Siwali Swantika
?
International trade unions like ITUC need to be less combative, maybe most ar...
International trade unions like ITUC need to be less combative, maybe most ar...International trade unions like ITUC need to be less combative, maybe most ar...
International trade unions like ITUC need to be less combative, maybe most ar...
Eric Gyllenhaal
?
gebiedsdossier Heelsumse Beek en Wolfhezer Beek
gebiedsdossier Heelsumse Beek en Wolfhezer Beekgebiedsdossier Heelsumse Beek en Wolfhezer Beek
gebiedsdossier Heelsumse Beek en Wolfhezer Beek
Marieke Brouwer-te Molder
?
Grand Traverse Resort deck
Grand Traverse Resort deckGrand Traverse Resort deck
Grand Traverse Resort deck
Nick Oliver
?
Cmsd percuma updated
Cmsd percuma updatedCmsd percuma updated
Cmsd percuma updated
iiza hass
?
HR Tech Advisor #SHRM15 Videos
HR Tech Advisor #SHRM15 Videos HR Tech Advisor #SHRM15 Videos
HR Tech Advisor #SHRM15 Videos
HR Tech Advisor
?
CRISIS MIGRATION: A NEW ROLE TRADE UNION?
CRISIS MIGRATION: A NEW ROLE TRADE UNION? CRISIS MIGRATION: A NEW ROLE TRADE UNION?
CRISIS MIGRATION: A NEW ROLE TRADE UNION?
Eric Gyllenhaal
?
Datasheet Fluke 8508A. Hubungi PT. Siwali Swantika 021-45850618
Datasheet Fluke 8508A. Hubungi PT. Siwali Swantika 021-45850618Datasheet Fluke 8508A. Hubungi PT. Siwali Swantika 021-45850618
Datasheet Fluke 8508A. Hubungi PT. Siwali Swantika 021-45850618
PT. Siwali Swantika
?
Rich ITUC Needs To Do More For Unskilled Laborers, Reports ANI. Report of Sh...
Rich ITUC Needs To Do More For Unskilled Laborers, Reports ANI. Report of Sh...Rich ITUC Needs To Do More For Unskilled Laborers, Reports ANI. Report of Sh...
Rich ITUC Needs To Do More For Unskilled Laborers, Reports ANI. Report of Sh...
Eric Gyllenhaal
?

Similar to Tyrosine sulfation lecture(edited) (20)

molecular-biology-presentation.pdf
molecular-biology-presentation.pdfmolecular-biology-presentation.pdf
molecular-biology-presentation.pdf
elistemidayo
?
MRSA
MRSAMRSA
MRSA
Riyaz Sheriff
?
SAR OF NNRT INHIBITORS, CCR INHIBITORS AND OROTEAS INHIBITORS.pptx
SAR OF NNRT INHIBITORS, CCR INHIBITORS AND OROTEAS INHIBITORS.pptxSAR OF NNRT INHIBITORS, CCR INHIBITORS AND OROTEAS INHIBITORS.pptx
SAR OF NNRT INHIBITORS, CCR INHIBITORS AND OROTEAS INHIBITORS.pptx
Kawalyasteven
?
1st Rotation Presentation
1st Rotation Presentation1st Rotation Presentation
1st Rotation Presentation
Stella Kounadi
?
pharmaceutical chemistry HIV and antiretroviral drugs
pharmaceutical chemistry HIV  and antiretroviral drugspharmaceutical chemistry HIV  and antiretroviral drugs
pharmaceutical chemistry HIV and antiretroviral drugs
richpharm9
?
HIV AND AIDS TREATMENT 2015
HIV AND AIDS TREATMENT 2015HIV AND AIDS TREATMENT 2015
HIV AND AIDS TREATMENT 2015
Kasarla Dr Ramesh
?
mole5-biology.pdf
mole5-biology.pdfmole5-biology.pdf
mole5-biology.pdf
elistemidayo
?
Targeted therapy in lung cancer
Targeted therapy in lung cancerTargeted therapy in lung cancer
Targeted therapy in lung cancer
Shriram Shenoy
?
14.tyrosine kinase
14.tyrosine kinase14.tyrosine kinase
14.tyrosine kinase
Dr SANTHIPRIYA GOPASANA
?
Lupus
LupusLupus
Lupus
Saveetha Medical College
?
Bacteriology & Immunology of Leprosy
Bacteriology & Immunology of LeprosyBacteriology & Immunology of Leprosy
Bacteriology & Immunology of Leprosy
Jerriton Brewin
?
Recent advances in the Anticancer treatment
Recent advances in the Anticancer treatmentRecent advances in the Anticancer treatment
Recent advances in the Anticancer treatment
Dr. Siddhartha Dutta
?
MI-2 & MDA-5.pptx sms mc Jaipur Rajasthan
MI-2 & MDA-5.pptx sms mc Jaipur RajasthanMI-2 & MDA-5.pptx sms mc Jaipur Rajasthan
MI-2 & MDA-5.pptx sms mc Jaipur Rajasthan
dineshdandia
?
hiv infection.pptx
hiv infection.pptxhiv infection.pptx
hiv infection.pptx
Johnmvula3
?
Antimycobacterial drugs note Antimycobacterial
Antimycobacterial drugs note AntimycobacterialAntimycobacterial drugs note Antimycobacterial
Antimycobacterial drugs note Antimycobacterial
IgweSolomon4
?
Aids2008talk
Aids2008talkAids2008talk
Aids2008talk
Terrence Brann
?
Pathophysiology Chemotherapy of Cancer
Pathophysiology Chemotherapy of CancerPathophysiology Chemotherapy of Cancer
Pathophysiology Chemotherapy of Cancer
shaheen begum
?
An Overview of Carcinogenesis and theories of neoplasia.ppt
An Overview of Carcinogenesis and theories of neoplasia.pptAn Overview of Carcinogenesis and theories of neoplasia.ppt
An Overview of Carcinogenesis and theories of neoplasia.ppt
komalasb
?
HIV LECTURE FOR MBBS AND POST GRADUATE.pptx
HIV LECTURE FOR MBBS AND POST GRADUATE.pptxHIV LECTURE FOR MBBS AND POST GRADUATE.pptx
HIV LECTURE FOR MBBS AND POST GRADUATE.pptx
Dr. Swati Rai
?
molecular biology and Target therapy in lung cancer
molecular biology and Target therapy in lung cancermolecular biology and Target therapy in lung cancer
molecular biology and Target therapy in lung cancer
Rikin Hasnani
?
molecular-biology-presentation.pdf
molecular-biology-presentation.pdfmolecular-biology-presentation.pdf
molecular-biology-presentation.pdf
elistemidayo
?
SAR OF NNRT INHIBITORS, CCR INHIBITORS AND OROTEAS INHIBITORS.pptx
SAR OF NNRT INHIBITORS, CCR INHIBITORS AND OROTEAS INHIBITORS.pptxSAR OF NNRT INHIBITORS, CCR INHIBITORS AND OROTEAS INHIBITORS.pptx
SAR OF NNRT INHIBITORS, CCR INHIBITORS AND OROTEAS INHIBITORS.pptx
Kawalyasteven
?
1st Rotation Presentation
1st Rotation Presentation1st Rotation Presentation
1st Rotation Presentation
Stella Kounadi
?
pharmaceutical chemistry HIV and antiretroviral drugs
pharmaceutical chemistry HIV  and antiretroviral drugspharmaceutical chemistry HIV  and antiretroviral drugs
pharmaceutical chemistry HIV and antiretroviral drugs
richpharm9
?
Targeted therapy in lung cancer
Targeted therapy in lung cancerTargeted therapy in lung cancer
Targeted therapy in lung cancer
Shriram Shenoy
?
Bacteriology & Immunology of Leprosy
Bacteriology & Immunology of LeprosyBacteriology & Immunology of Leprosy
Bacteriology & Immunology of Leprosy
Jerriton Brewin
?
Recent advances in the Anticancer treatment
Recent advances in the Anticancer treatmentRecent advances in the Anticancer treatment
Recent advances in the Anticancer treatment
Dr. Siddhartha Dutta
?
MI-2 & MDA-5.pptx sms mc Jaipur Rajasthan
MI-2 & MDA-5.pptx sms mc Jaipur RajasthanMI-2 & MDA-5.pptx sms mc Jaipur Rajasthan
MI-2 & MDA-5.pptx sms mc Jaipur Rajasthan
dineshdandia
?
hiv infection.pptx
hiv infection.pptxhiv infection.pptx
hiv infection.pptx
Johnmvula3
?
Antimycobacterial drugs note Antimycobacterial
Antimycobacterial drugs note AntimycobacterialAntimycobacterial drugs note Antimycobacterial
Antimycobacterial drugs note Antimycobacterial
IgweSolomon4
?
Pathophysiology Chemotherapy of Cancer
Pathophysiology Chemotherapy of CancerPathophysiology Chemotherapy of Cancer
Pathophysiology Chemotherapy of Cancer
shaheen begum
?
An Overview of Carcinogenesis and theories of neoplasia.ppt
An Overview of Carcinogenesis and theories of neoplasia.pptAn Overview of Carcinogenesis and theories of neoplasia.ppt
An Overview of Carcinogenesis and theories of neoplasia.ppt
komalasb
?
HIV LECTURE FOR MBBS AND POST GRADUATE.pptx
HIV LECTURE FOR MBBS AND POST GRADUATE.pptxHIV LECTURE FOR MBBS AND POST GRADUATE.pptx
HIV LECTURE FOR MBBS AND POST GRADUATE.pptx
Dr. Swati Rai
?
molecular biology and Target therapy in lung cancer
molecular biology and Target therapy in lung cancermolecular biology and Target therapy in lung cancer
molecular biology and Target therapy in lung cancer
Rikin Hasnani
?

Tyrosine sulfation lecture(edited)

  • 1. VBMS 7180 Receptorology Presented by: Chris Ramhold Ph.D. Student 16-March-15 TYROSINE SULFATION OF THE AMINO TERMINUS OF CCR5 FACILITATES HIV-1 ENTRY
  • 2. ? Setting the stage ? Post-translational modification C Tyrosine Sulfation ? Chemokine receptors C What are chemokine receptors? ? Characteristics and families C How do chemokine receptors work? C CCR5 ? HIV C Classification ? Primary research article OVERVIEW
  • 3. ? Previously studied N- terminus region of CCR5 ? Site directed mutagenesis PRIOR RESEARCH Farzan, Michael, et al. "A tyrosine-rich region in the N terminus of CCR5 is important for human immunodeficiency virus type 1 entry and mediates an association between gp120 and CCR5." Journal of virology 72.2 (1998): 1160-1164.
  • 4. ? N-terminus important for internalization ? Found something interesting ? Half of the mutants were originally tyrosine PRIOR RESEARCH Farzan, Michael, et al. "A tyrosine-rich region in the N terminus of CCR5 is important for human immunodeficiency virus type 1 entry and mediates an association between gp120 and CCR5." Journal of virology 72.2 (1998): 1160-1164.
  • 5. ? Aromatic- Benzene ? Reactive hydroxyl group ? Can be phosphorylated or sulfated QUICK REVIEW- TYROSINE
  • 6. ? Modifications occurring after translation ? Responsible for proteome diversity ? Most often includes covalent attachment of functional groups POSTTRANSLATIONAL MODIFICATION http://asfaculty.syr.edu/pages/chem/_images/hougland_fig1.jpg
  • 7. ? The transfer of a sulfate to the hydroxyl group of the tyrosine residue ? Enzymatic assistance by tyrosylprotein sulfotransferase (TPST) ? Occurs in the golgi ? Donor molecule 3- phosphoadenosine- 5phosphosulfate (PAPS) TYROSINE SULFATION Kanan, Yogita, and Muayyad R. Al-Ubaidi. "Tyrosine OSulfation: An Overview." JSM 1.1 (2013): 1003.
  • 8. ? Receptors for cytokines that induce chemotaxis ? 7TM structure C Member of GPCR ? Four classes C C, CC, CXC, and CX3C CHEMOKINE RECEPTORS http://www.biolegend.com/media_assets/chemokine_receptors/CK_structure.jpg
  • 9. ? Chemokine binds N-terminus of receptor C Binding enhanced by tyrosine sulfation ? Complex interacts with cytoplasmic face of receptor to activate signaling CHEMOKINE RECEPTOR BINDING MODEL Ludeman, Justin P., and Martin J. Stone. "The structural role of receptor tyrosine sulfation in chemokine recognition." British journal of pharmacology 171.5 (2014): 1167-1179.
  • 10. ? Expressed on T-cells, macrophages, dendritic cells, eosinophils and microglia ? Most common receptor for HIV-1 internalization ? Most common target of HIV drugs C CCR5 receptor antagonists C Maraviroc (Pfizer) C Block CCR5 binding site CHEMOKINE RECEPTOR TYPE 5 http://idshowcase.lshtm.ac.uk/id501/ID501/S1S4/ID501_S1S4_030_010.html
  • 11. ? Human immunodeficiency virus (HIV) C Lentivirus, group of retroviruses ? Cause of AIDS (acquired immunodeficiency syndrome) ? Viral RNA is reverse transcribed and integrated into host DNA ? Infects immune cells C CD4+ T cells C Macrophages C Dendritic cells HIV http://s.hswstatic.com/gif/aids-hiv-anatomy.gif
  • 12. ? HIV-1 C High virulence C High infectivity C Global ? HIV-2 C Moderate virulence C Low infectivity C Localized to West Africa HIV CLASSIFICATIONS http://treasuresoftheinternet.org/health/aids/us_census/aids_maps/Map3c.gif
  • 13. ? Research group published paper regarding N-terminus of CCR5 receptor ? Gradual increase in focus ? Need to identify targets for HIV therapy THE PAPER
  • 14. ? N-terminal CCR5 residues important ? Tyrosines specifically ? Sulfate plays several roles in HIV-1 internalization C Virus-cell interactions C Inhibit internalization by binding gp120* C Inhibit viral replication TYROSINE SULFATION OF THE AMINO TERMINUS OF CCR5 FACILITATES HIV-1 ENTRY Baleux, Fran?oise, et al. "A synthetic CD4Cheparan sulfate glycoconjugate inhibits CCR5 and CXCR4 HIV-1 attachment and entry." Nature chemical biology 5.10 (2009): 743-748.
  • 15. ? Sulfation common in chemokines and HIV-1 env glycoproteins ? Is CCR5 sulfated? ? Red- Negative controls ? Blue- Stably transfected CD4/CCR5 ? Sulfate is specifically incorporated in CCR5 POSTTRANSLATIONAL MODIFICATION BY SULFATE [35S] C [35S] M [35S] Sulfate CCR5 CCR5CD4 CD4 Label IP
  • 16. ? Sulfation occurs at either O-, N-linked glycosylation sites, or on tyrosines ? Endoglycosidase F (endo F) & Tunicamycin treatment ineffective against CCR5 C Cleavage and blockage of N-linked glycosylation C Not N-linked glycosylation CCR5 SITE OF SULFATION (N-LINKED GLYCOSYLATION)
  • 17. ? Red- Negative controls C No expression of CD4 or CCR5 ? IP with CCR5 antibody ? 1, 4, 5, & 8- Enzyme buffer ? 2 & 6 - Neuraminidase (green) ? 3 & 7 C Four O-glycosidases (yellow) ? [35S] Sulfate still present after treatments C Sulfation must occur on tyrosines CCR5 SITE OF SULFATION (O-LINKED GLYCOSYLATION) [35S] Sulfate [35S] C & M
  • 18. ? Thin layer chromatography ? Labeled CCR5 from previous experiment removed from gel ? Digested, pH neutralized, and run next to unlabeled tyrosine and serine sulfates (1 & 3) ? 2 & 4 show presence of labeled Tyrosine sulfate ? Presence of 35S due to Tyrosine sulfation CCR5 MODIFICATIONS (TYROSINE SULFATION) Ninhydrin X-ray film
  • 19. ? Negative control cells treated with sulfate (white) ? Treatment with chlorate- inhibit sulfation (gray) ? Treatment with sulfate- allow sulfation (thick line) ? 2D7- Antibody specific to 2nd extracellular loop ? No difference between treatments ? Sulfation does not interfere with binding- no alteration in 2nd extracellular loop ROLE OF TYROSINE SULFATION FACS- Fluorescence Activated Cell Sorting
  • 20. ? Negative control cells treated with sulfate (white) ? Treatment with chlorate- inhibit sulfation (gray) ? Treatment with sulfate- allow sulfation (thick line) ? 5C7- Antibody specific to N terminus ? Decreased binding of 5C7 when sulfation is inhibited ? N-terminus recognition altered ? No effect on CCR5 expression levels (AUC) ROLE OF TYROSINE SULFATION FACS- Fluorescence Activated Cell Sorting
  • 21. ? Confirmation of results C Mutated tyrosine to phenylalanine C Similar results (data not shown) C Decreased recognition specific to loss of sulfate ROLE OF TYROSINE SULFATION
  • 22. ? Chlorate treatment (circles/red) ? Sulfate treatment (squares/blue) ? 125I-labeled MIP-1a incubated with CCR5 transfected cells ? Increasing amounts of MIP-1a competitor added ? Loss of sulfate leads to decreased binding of native ligand MIP-1a ? Sulfate-treated cells with 2D7 antibody (diamond) ? Negative control cells (triangle) ROLE OF TYROSINE SULFATION (CCR5 LIGANDS) MIP= Macrophage inflammatory protein-1a a.k.a. CCL3
  • 23. ? Chlorate treatment (circles/red) ? Sulfate treatment (squares/blue) ? 125I-labeled MIP-1 incubated with CCR5 transfected cells ? Increasing amounts of MIP-1 competitor added ? Loss of sulfate leads to decreased binding of native ligand MIP-1 ? Sulfate-treated cells with 2D7 antibody (diamond) ? Negative control cells (triangle) ROLE OF TYROSINE SULFATION (CCR5 LIGANDS) MIP= Macrophage inflammatory protein-1 a.k.a. CCL4
  • 24. ? Chlorate treatment (circles/red) ? Sulfate treatment (squares/blue) ? 125I-labeled gp120 complexed with soluble CD4 incubated with CCR5 transfected cells ? Typically binds with high affinity ? Loss of sulfate leads to decreased binding efficiency ? Sulfate-treated cells with 2D7 antibody (diamond) ? Negative control cells (triangle) ROLE OF TYROSINE SULFATION (CCR5 LIGANDS) sYU2- HIV-1 env gp120, strain YU2
  • 25. ? Which of the four tyrosines are sulfated? ? CCR5 construct used ? Nine amino acid tag C Motif from rhodopsin C Identified with anti-rhodopsin antibody 1D4 ? New cell line used C HeLa cells C Six transfection lines created ? Mock transfection- Empty vector ? All four tyrosines replaced with phenylalaline ? Four constructs where three of four tyrosines are replaced with phenylalaline ? Assay for sulfation IDENTIFICATION OF SULFATED TYROSINES
  • 26. ? HeLa transfected cell lysates ? IP with 1D4 antibody ? WT does incorporate sulfate ? FFFF construct fails to incorporate sulfate ? Only YFFF could incorporate sulfate C Faint bands on other 3 constructs after extended exposure (not shown) C FYYY (next 2 slides) showed sulfation greater than 3 constructs previously mentioned IDENTIFICATION OF SULFATED TYROSINES
  • 27. ? HeLa transfected cell lysates ? IP with 1D4 antibody ? WT does incorporate sulfate ? Sulfation greater in three adjacent tyrosine construct ? Due to the absence of phenylalanine? ? Due to the presence of neighboring tyrosines? ? Replace phenylalaline with AA that mimics a sulfated tyrosine SULFATION DEPENDENT ON NEIGHBORING RESIDUES
  • 28. ? HeLa transfected cell lysates ? IP with 1D4 antibody ? WT does incorporate sulfate ? FFFF construct fails to incorporate sulfate ? New panel of mutants using aspartic acid vs phenylalanine ? Sulfation of single tyrosines ? Negative charge may assist in sulfation of neighboring tyrosines SULFATION OF CCR5 TYROSINES DEPENDENT ON N- TERMINAL RESIDUES
  • 29. ? Do sulfotyrosines in CCR5 play a role in HIV-1 internalization? ? Generate pseudotype viruses C Virus containing CAT reporter gene C Lacking env gene ? Host cell expresses env gene (pseudotyped gene) ? Generate PV, capable of only one round of infection ? Use envelope glycoproteins ADA, YU2, and 89.6 ( from strains that use CCR5 for entry) SULFATION OF CCR5 TYROSINES DEPENDENT ON N- TERMINAL RESIDUES Tani, Hideki, Shigeru Morikawa, and Yoshiharu Matsuura. "Development and applications of VSV vectors based on cell tropism." Frontiers in microbiology 2 (2011).
  • 30. ? YU2 pseudotyped HIV-1 ? WT CCR5 (black squares/ blue) ? FFFF CCR5 construct (circles/ red) ? Negative control (triangle) ? Lack of tyrosine residues resulted in decrease of viral entry HIV-1 ENTRY EFFICIENCY MODULATED BY SULFATED TYROSINES ? % entry relative to wild type CCR5
  • 31. ? ADA pseudotyped HIV-1 ? WT CCR5 (black squares/ blue) ? FFFF CCR5 construct (circles/ red) ? Negative control (triangle) ? Lack of tyrosine residues resulted in greater decrease of viral entry relative to YU2 pseudotyped HIV-1 HIV-1 ENTRY EFFICIENCY MODULATED BY SULFATED TYROSINES ? % entry relative to wild type CCR5
  • 32. ? 89.6 pseudotyped HIV-1 ? WT CCR5 (black squares/ blue) ? FFFF CCR5 construct (circles/ red) ? Negative control (triangle) ? Lack of tyrosine residues resulted in greatest decrease of viral entry relative to all tested pseudotypes of HIV-1 HIV-1 ENTRY EFFICIENCY MODULATED BY SULFATED TYROSINES ? % entry relative to wild type CCR5
  • 33. ? YU2 pseudotyped HIV-1 ? WT CCR5 (YYYY) standard ? Test entry mediated by sulfate group vs phenyl ring ? Presence of sulfated tyrosine leads to significant viral entry HIV-1 YU2 ENTRY ENHANCED BY SULFATION OF N- TERMINAL TYROSINE RESIDUES
  • 34. ? ADA pseudotyped HIV-1 ? WT CCR5 (YYYY) standard ? Test entry mediated by sulfate group vs phenyl ring ? Presence of sulfated tyrosine leads to significant viral entry HIV-1 ADA ENTRY ENHANCED BY SULFATION OF N- TERMINAL TYROSINE RESIDUES
  • 35. ? AA sequences of N- termini of related receptors ? All but two are known HIV-1/SIV coreceptors* ? Tyrosines and adjacent AAs are bolded DO THESE FINDINGS TRANSLATE TO OTHER RELATED RECEPTORS? Receptors incorporating [35S] sulfate
  • 36. ? CXCR4 tested in human embryonic kidney cells expressing SV40 large T antigen (HEK 293T) ? CXCR4 contained c-terminal tag recognized by Ab 1D4 ? Receptor labeled with [35S] sulfate ? Band indicates presence of [35S] sulfate in CXCR4 expressing cells DO THESE FINDINGS TRANSLATE TO OTHER RELATED RECEPTORS?
  • 37. ? Confirmed CCR5 is sulfated ? Site of sulfation on tyrosines C Confirmed tyrosine sulfation ? Tyrosine sulfation occurs on N-terminus C Affects binding but not receptor expression C Blockage of sulfation leads to decreased binding ability of native ligands ? Tyrosine sulfation enhanced by negative charge of proximal AAs ? Sulfated tyrosines are important in HIV-1 entry ? Sulfation may play a role in other coreceptors and the internalization of HIV-1 TYROSINE SULFATION OF THE AMINO TERMINUS OF CCR5 FACILITATES HIV-1 ENTRY
  • 38. ? Baleux, Fran?oise, et al. "A synthetic CD4Cheparan sulfate glycoconjugate inhibits CCR5 and CXCR4 HIV-1 attachment and entry." Nature chemical biology 5.10 (2009): 743-748. ? Farzan, Michael, et al. "A tyrosine-rich region in the N terminus of CCR5 is important for human immunodeficiency virus type 1 entry and mediates an association between gp120 and CCR5." Journal of virology 72.2 (1998): 1160-1164. ? Farzan, Michael, et al. "Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry." Cell 96.5 (1999): 667-676. ? Kanan, Yogita, and Muayyad R. Al-Ubaidi. "Tyrosine OSulfation: An Overview." JSM 1.1 (2013): 1003. ? Tani, Hideki, Shigeru Morikawa, and Yoshiharu Matsuura. "Development and applications of VSV vectors based on cell tropism." Frontiers in microbiology 2 (2011). ? http://asfaculty.syr.edu/pages/chem/_images/hougland_fig1.jpg ? http://www.biolegend.com/media_assets/chemokine_receptors/CK_structure.jpg ? http://s.hswstatic.com/gif/aids-hiv-anatomy.gif ? http://treasuresoftheinternet.org/health/aids/us_census/aids_maps/Map3c.gif ? http://idshowcase.lshtm.ac.uk/id501/ID501/S1S4/ID501_S1S4_030_010.html REFERENCES

Editor's Notes

  • #19: Ninhydrin- Blue color produced when reacting with primary and secondary amines
  • #20: Ninhydrin- Blue color produced when reacting with primary and secondary amines
  • #21: Ninhydrin- Blue color produced when reacting with primary and secondary amines
  • #22: Ninhydrin- Blue color produced when reacting with primary and secondary amines
  • #23: Ninhydrin- Blue color produced when reacting with primary and secondary amines
  • #24: Ninhydrin- Blue color produced when reacting with primary and secondary amines
  • #25: Ninhydrin- Blue color produced when reacting with primary and secondary amines
  • #26: Human cervical cancer line
  • #27: Human cervical cancer line
  • #28: Human cervical cancer line
  • #29: Human cervical cancer line
  • #30: Human cervical cancer line
  • #31: Human cervical cancer line
  • #32: Human cervical cancer line
  • #33: Human cervical cancer line
  • #34: Human cervical cancer line
  • #35: Human cervical cancer line
  • #36: Human cervical cancer line
  • #37: Human cervical cancer line
  • #38: Human cervical cancer line
  • #39: Human cervical cancer line